Lamivudine Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 100 mg, 150 mg, 300 mg
Reference Brands: Epivir®, Epivir-HBV® (US & EU)
Category:
Hepatitis
Lamivudine Tablets are oral antiviral medications used to manage chronic Hepatitis B infection. As a nucleoside reverse transcriptase inhibitor (NRTI), Lamivudine reduces viral replication and liver inflammation. Commonly available in 100 mg strength for Hepatitis B treatment, it is approved by regulatory authorities in the EU and US. Suitable for inclusion in pharma B2B supply chains, Lamivudine is trusted for its safety, efficacy, and global therapeutic relevance.
Lamivudine is available in Tablet
and strengths such as 100 mg, 150 mg, 300 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Lamivudine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Lamivudine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Lamivudine Tablets are antiviral medications primarily used to treat chronic Hepatitis B virus (HBV) infection and HIV-1 as part of combination therapy. As a nucleoside reverse transcriptase inhibitor (NRTI), Lamivudine effectively suppresses viral replication, reducing liver inflammation and disease progression. Available in 100 mg tablets for hepatitis B and 150–300 mg for HIV, it is widely prescribed and globally trusted. Manufactured under stringent EU-GMP and USFDA standards, Lamivudine is an essential product in hospital procurement and pharma B2B export portfolios. Its proven safety, cost-effectiveness, and global demand make it a key antiviral in the EU and US healthcare markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing